Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
Jennifer L. Bishop, Daksh Thaper, Amina Zoubeidi
Cancers (2014) Vol. 6, Iss. 2, pp. 829-859
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi, Frédéric J. de Sauvage
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 1, pp. 39-56
Closed Access | Times Cited: 603
Constitutive activation of STAT3 in breast cancer cells: A review
Kasturi Banerjee, Haluk Resat
International Journal of Cancer (2015) Vol. 138, Iss. 11, pp. 2570-2578
Open Access | Times Cited: 548
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair Davies, Himisha Beltran, Amina Zoubeidi
Nature Reviews Urology (2018) Vol. 15, Iss. 5, pp. 271-286
Closed Access | Times Cited: 356
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Bernd Groner, Viktoria von Manstein
Molecular and Cellular Endocrinology (2017) Vol. 451, pp. 1-14
Closed Access | Times Cited: 274
JAK-STAT signaling in cancer: From cytokines to non-coding genome
Jan Pěnčík, Hà Phạm, Johannes Schmoellerl, et al.
Cytokine (2016) Vol. 87, pp. 26-36
Open Access | Times Cited: 200
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Rajdeep Das, Philip A. Gregory, Rayzel C. Fernandes, et al.
Cancer Research (2016) Vol. 77, Iss. 4, pp. 1021-1034
Open Access | Times Cited: 107
The dual regulatory role of miR-204 in cancer
Tianqi Li, Hongjie Pan, Li R
Tumor Biology (2016) Vol. 37, Iss. 9, pp. 11667-11677
Open Access | Times Cited: 106
MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway
Ningning He, Yangyang Kong, Xudan Lei, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 92
Expression of STAT3 in Prostate Cancer Metastases
Nicholas Don‐Doncow, Felicia Marginean, Ilsa M. Coleman, et al.
European Urology (2016) Vol. 71, Iss. 3, pp. 313-316
Open Access | Times Cited: 91
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
Marc Cárceles-Cordon, William Kevin Kelly, Leonard G. Gomella, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 5, pp. 292-307
Open Access | Times Cited: 76
Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
Marzieh Ehsani, Faith Oluwakemi David, Aria Baniahmad
Cancers (2021) Vol. 13, Iss. 7, pp. 1534-1534
Open Access | Times Cited: 61
Cancer stem cell in prostate cancer progression, metastasis and therapy resistance
Poornima Verma, Neha Shukla, Shivani Kumari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188887-188887
Closed Access | Times Cited: 36
STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
Dayson Moreira, Tomasz Adamus, Xingli Zhao, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 23, pp. 5948-5962
Open Access | Times Cited: 75
Prostate Cancer
Aradhana Rani, Prokar Dasgupta, John J. Murphy
American Journal Of Pathology (2019) Vol. 189, Iss. 11, pp. 2119-2137
Open Access | Times Cited: 71
Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer
Tyler Keeley, Diane Costanzo-Garvey, Leah M. Cook
Trends in cancer (2019) Vol. 5, Iss. 12, pp. 789-798
Closed Access | Times Cited: 69
Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells
Haseeb Zubair, Arun Bhardwaj, Aamir Ahmad, et al.
Nutrition and Cancer (2017) Vol. 69, Iss. 6, pp. 932-942
Open Access | Times Cited: 63
Helicobacter pylori Activates IL‐6‐STAT3 Signaling in Human Gastric Cancer Cells: Potential Roles for Reactive Oxygen Species
Juan‐Yu Piao, Hee Geum Lee, Su‐Jung Kim, et al.
Helicobacter (2016) Vol. 21, Iss. 5, pp. 405-416
Closed Access | Times Cited: 61
Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
Shengling Fu, Xiang Chen, Hui‐Wen Lo, et al.
Cancer Letters (2019) Vol. 448, pp. 11-19
Closed Access | Times Cited: 61
A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer
Fionnuala Crowley, Michelle Sterpi, Conor Buckley, et al.
Research and Reports in Urology (2021) Vol. Volume 13, pp. 457-472
Open Access | Times Cited: 49
The Anti-cancer Effect of Olea europaea L. Products: a Review
Chrystalla Antoniou, Jonathon Hull
Current Nutrition Reports (2021) Vol. 10, Iss. 1, pp. 99-124
Open Access | Times Cited: 41
BDNF and its signaling in cancer
Mohammad Malekan, Sasan Salehi Nezamabadi, Elham Samami, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2621-2636
Closed Access | Times Cited: 33
MicroRNA‐204‐5p: A pivotal tumor suppressor
Fan Yang, Zehua Bian, Peiwen Xu, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3185-3200
Open Access | Times Cited: 32
Prostate cancer immunotherapy
Iraklis Mitsogiannis, Lazaros Tzelves, Athanasios Dellis, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 5, pp. 577-590
Closed Access | Times Cited: 29
Role of STAT3 pathway in genitourinary tumors
Matteo Santoni, Alessandro Conti, Francesco Piva, et al.
Future Science OA (2015) Vol. 1, Iss. 3
Open Access | Times Cited: 62
Metformin represses androgen‐dependent and androgen‐independent prostate cancers by targeting androgen receptor
Yan Wang, Gaolei Liu, Dali Tong, et al.
The Prostate (2015) Vol. 75, Iss. 11, pp. 1187-1196
Closed Access | Times Cited: 60
Page 1 - Next Page

Scroll to top